Clinical Director Prostate Cancer Research at The Kinghorn Cancer Centre

10 Jul 2013

Opened late last year by Prime Minister Gillard, The Kinghorn Cancer Centre is a joint venture between the Garvan Institute of Medical Research and St Vincent’s Hospital.

Associate Professor Phillip Stricker was appointed Clinical Director Prostate Cancer Research at The Kinghorn Cancer Centre. In response to the $5.5 million dollars funding over four years, he said, “The two organisations have already built a strong international reputation for the quality of their combined prostate cancer research, and this funding will further bolster that. Over many years, the Garvan and St Vincents Prostate Cancer Centre has pioneered new diagnostic techniques, introduced new biomarkers for early and advanced prostate cancer, and introduced the study of quality of life outcomes. Genomic research is a strong and welcome addition to an already-potent arsenal of tools.”

ABC News: focal therapy

19 Apr 2013

Reporter Sophie Scott's story, New pain-free treatment for prostate cancer, investigates the new and relatively painless treatment referred to generally as focal therapy. Dr Sricker, who is trialling focal therapies at St Vincent's Hospital, gives an insight into the Nanoknife treatment.

Nanoknife - the first case

28 Feb 2013

The first case of Nanoknife treatment for prostate cancer was performed in late February. Dr Stricker said he was pleased with the outcome and welcomed a leading edge surgical technology that would allow yet another option when tailoring treatments for patients. In particular, he felt that that the Nanoknife procedure coould help minimise side-effects. Nanoknife is a new technology designed for precise and effective surgical ablation.

Read more about this case in Jill Argo's article for the Australian Financial Review, "Cutting edge treatment for prostate cancer".

Robotic surgery prevails

18 Jan 2013

Dr Stricker performed just over 250 surgical cases in 2012, one of the largest series in Australasia. When asked about the breakdown between robotic and open, he said that as per previous years over 200 were robotic. Given the outcomes, he believes it wil continue as a favoured choice for surgical treatment. Dr Stricker has now performed over 1,000 robotic cases.